Kelly Deck - 26 Mar 2024 Form 4 Insider Report for Inhibrx, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INBX	Stock Option (right to buy)	Options Exercise	$14,018	-396	-2.2%	$35.40	17,624	26 Mar 2024	Common Stock	396	$10.52	Direct	F1
transaction	INBX	Stock Option (right to buy)	Options Exercise	$14,726	-416	-4.3%	$35.40	9,167	26 Mar 2024	Common Stock	416	$34.16	Direct	F2
transaction	INBX	Stock Option (right to buy)	Options Exercise	$51,649	-1,459	-9.1%	$35.40	14,583	26 Mar 2024	Common Stock	1,459	$33.63	Direct	F3
transaction	INBX	Stock Option (right to buy)	Options Exercise	$22,125	-625	-2.9%	$35.40	21,250	26 Mar 2024	Common Stock	625	$23.30	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on November 26, 2019, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F2	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 11, 2023, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F3	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F4	Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.